Board of Directors

Dr. Nelson served as a member on the Board of Directors at Medtronic beginning in 1980. He joined Medtronic as Executive Vice President in 1986 and was elected Vice Chairman in 1988, a position he held until his retirement. Before joining Medtronic, Dr. Nelson practiced surgery from 1969 to 1986, and served as Chairman of the Board and Chief Executive Officer for American MedCenters, Inc. from 1984 to 1986. From 1975 to 1986, he also served as Chairman, President and Chief Executive Officer of Park Nicollet Medical Center, a large multi-specialty group practice in Minneapolis. Dr. Nelson received his Bachelor of Arts Degree from Harvard College in 1959 and his M.D. Degree from the University of Minnesota in 1963. He completed his training in general surgery at Hennepin County General Hospital, Minneapolis, in 1969. Dr. Nelson currently serves on seven corporate boards.

Mr. Blackey is the President and Chief Operating Office (COO) of Holiday Companies, a leader in the petroleum and convenience store industry with over $2 billion in revenues. Prior to joining Holiday Companies in 2004, Mr. Blackey was a Senior Partner at the accounting firms of Arthur Anderson LLP and Ernst & Young LLP. Mr. Blackey was instrumental in leading several clients through both initial and secondary public offerings, and played a key role in numerous transactions with clients Target Corporation, Carlson Companies, Polaris Industries and CH Robinson Worldwide, among others.

Mr. Friedman is the Managing Partner of Easton Capital Investment Group. Prior to founding Easton Capital, Mr. Friedman was the founder and Managing General Partner of Security Pacific Capital Investors, a $200 million private equity fund geared towards expansion financings and recapitalizations. Previous to Security Pacific, he was a Managing Director and Partner at E.M. Warburg, Pincus & Co., Inc. Mr. Friedman also served as a Managing Director of Atrium Capital Corp., an investment firm. He holds a J.D. degree from Yale Law School and a B.A. degree from Yale College. Mr. Friedman currently serves on the Boards of Renovis, Trellis Bioscience, Xoft, Inc., Sanarus, Inc., YM BioSciences and Assistive Technology. He is Co-Chairman of the Cold Spring Harbor President’s Council.

Dr. Hartzler gained international prominence as a cardiologist during 23 years of practice in interventional cardiology. He served most recently, from 1980 to 1995, as a consulting cardiologist with the Mid America Heart Institute of St. Luke’s Hospital in Kansas City, MO. Dr. Hartzler was the co-founder and director of four medical device companies, including Ventritex Inc. and IntraLuminal Therapeutics, Inc., and served as a consultant and/or director to seven additional companies, some of which were medical device companies. Dr. Hartzler has published numerous articles in medical and scientific journals on various aspects of cardiology, and has been a frequent lecturer on these topics. Dr. Hartzler is regarded as one of the pioneers of interventional cardiology.

Mr. Martin has been a driver in building shareholder value throughout the last ten years in three companies. Mr. Martin was appointed CSI’s Chief Executive Officer in February 2007 and has served on the board since August 15, 2006. Prior to that, Mr. Martin was Chief Operating Officer for FoxHollow Technologies, (IPO 2004) where he directed their commercial plan. Prior to FoxHollow, Mr. Martin was VP of Global Sales for Rita Medical Systems, (IPO 2000) and before that was Director of U.S. Sales for CardioThoracic Systems, (IPO 1996). Mr. Martin has also held sales and sales management positions for Procter & Gamble, Boston Scientific and Guidant Corporation. Mr. Martin currently serves on two boards.

Gus Lawlor has been a managing director of HealthCare Ventures since 2000. He was previously Chief Operating Officer of LeukoSite, Inc., a HealthCare Ventures III, IV, and V company. Before joining LeukoSite, he was Chief Financial Officer and Vice President of Corporate Development for Alpha-Beta Technology. He held similar positions at BioSurface Technology and Armstrong Pharmaceuticals. He was previously a management consultant with KPMG Peat Marwick. Mr. Lawlor is a member of the board of directors of the Slater Center in Providence, Rhode Island. He received a master’s degree in public and private management from Yale University.

Mr. Brown is involved in a variety of principal investment, advisory and board roles in the healthcare industry. He currently serves as a Senior Advisor for Health Evolution Partners, a healthcare focused growth equity investment firm. From 2007 to 2010, Mr. Brown served as a Managing Director for TPG Growth, where he focused on venture stage investments in medical device companies. Prior to TPG, Ned was a co-founder of Healthcare Investment Partners, a healthcare investment firm which made investments in medical devices and specialty pharmaceuticals. Before HIP, Ned had over 17 years experience as an investment banker focused on the healthcare industry, most recently as a Managing Director for Credit Suisse and Donaldson, Lufkin and Jenrette. Mr. Brown serves on the boards of Angiotech Pharmaceuticals (public), Cardiovascular Systems, Inc. (public) and Sleep Solutions Inc. (private). Mr. Brown received a BA in English from Middlebury College, and MBA from UCLA and attended graduate school at Oxford University for a Masters in English Literature.

Leslie L. Trigg  |  Director

Leslie currently serves as Executive Vice President, Marketing and Commercial Strategy for Lutonix, a medical device company in the drug-coated balloon space. Ms. Trigg most recently served as Chief Business Officer of AccessClosure, Inc. Before joining AccessClosure, Ms. Trigg was the Vice President, Marketing for FoxHollow Technologies, Inc from 2003 to mid-2006. Her commercial operations experience also includes positions as Business Unit Director at Cytyc Corporation and Director, Market Development at Pro-Duct Health, Inc prior to its acquisition by Cytyc. She has also held global marketing positions with Guidant Corporation. Ms. Trigg currently does commercialization advisory work for medical device companies in the cardiovascular space.  She received her undergraduate degree from Northwestern University and her MBA from the Haas School of Business, UC Berkeley.